These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 18158729)

  • 21. [Enhancement of the immune response in mice with a noval HCV DNA vaccine targeting NS3 to dendritic cells].
    Yin X; Wang W; Tan WJ; Deng Y; Guan J; Wen B; Chen H; Ruan L
    Bing Du Xue Bao; 2011 Jan; 27(1):44-9. PubMed ID: 21462505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune responses to hepatitis C virus structural and nonstructural proteins induced by plasmid DNA immunizations.
    Gordon EJ; Bhat R; Liu Q; Wang YF; Tackney C; Prince AM
    J Infect Dis; 2000 Jan; 181(1):42-50. PubMed ID: 10608749
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins.
    Pancholi P; Liu Q; Tricoche N; Zhang P; Perkus ME; Prince AM
    J Infect Dis; 2000 Jul; 182(1):18-27. PubMed ID: 10882577
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
    Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
    Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model.
    Encke J; zu Putlitz J; Geissler M; Wands JR
    J Immunol; 1998 Nov; 161(9):4917-23. PubMed ID: 9794426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of vaccine-induced immune responses to hepatitis C virus in rhesus macaques by altering priming before adenovirus boosting.
    Rollier C; Verschoor EJ; Paranhos-Baccala G; Drexhage JA; Verstrepen BE; Berland JL; Himoudi N; Barnfield C; Liljestrom P; Lasarte JJ; Ruiz J; Inchauspe G; Heeney JL
    J Infect Dis; 2005 Sep; 192(5):920-9. PubMed ID: 16088843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of potent cellular immune response in mice by hepatitis C virus NS3 protein with double-stranded RNA.
    Jin B; Wang RY; Qiu Q; Sugauchi F; Grandinetti T; Alter HJ; Shih JW
    Immunology; 2007 Sep; 122(1):15-27. PubMed ID: 17451465
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activation and differentiation of naïve CD4+ and CD8+ T cells into HCV core- and NS3-specific armed effector cells: a new role for CD4+ T cells.
    Krishnadas DK; Li W; Kumar R; Tyrrell LJ; Agrawal B
    Cell Immunol; 2009; 259(2):141-9. PubMed ID: 19616202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.
    Martin P; Parroche P; Chatel L; Barretto C; Beck A; Trépo C; Bain C; Lone YC; Inchauspé G; Fournillier A
    J Med Virol; 2004 Nov; 74(3):397-405. PubMed ID: 15368525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The combined application of nucleotide and amino acid sequences of NS3 hepatitis C virus protein, DNA encoding granulocyte macrophage colony-stimulating factor and inhibitor of regulatory T cells induces effective immune response against hepatitis C virus].
    Masalova OV; Lesnova EI; Shingarova LN; Tunitskaia VL; Ulanova TI; Burkov AN; Kushch AA
    Mol Biol (Mosk); 2012; 46(3):525-34. PubMed ID: 22888642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunization with a Recombinant Expression Vector Encoding NS3/NS4A of Hepatitis C Virus Genotype 3a Elicits Cell-Mediated Immune Responses in C57BL/6 Mice.
    Behzadi MA; Alborzi A; Kalani M; Pouladfar G; Dianatpour M; Ziyaeyan M
    Viral Immunol; 2016 Apr; 29(3):138-47. PubMed ID: 26909520
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunogenicity and heterologous protection in mice with a recombinant adenoviral-based vaccine carrying a hepatitis C virus truncated NS3 and core fusion protein].
    Guan J; Deng Y; Chen H; Yang Y; Wen B; Tan W
    Bing Du Xue Bao; 2015 Jan; 31(1):7-13. PubMed ID: 25997323
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous use of natural adjuvants and cell penetrating peptides improves HCV NS3 antigen-specific immune responses.
    Alizadeh S; Irani S; Bolhassani A; Sadat SM
    Immunol Lett; 2019 Aug; 212():70-80. PubMed ID: 31254535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T-cell vaccines that elicit effective immune responses against HCV in chimpanzees may create greater immune pressure for viral mutation.
    Zubkova I; Choi YH; Chang E; Pirollo K; Uren T; Watanabe H; Wells F; Kachko A; Krawczynski K; Major ME
    Vaccine; 2009 Apr; 27(19):2594-602. PubMed ID: 19428866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [DNA immunization with a plasmid containing gene of hepatitis C virus protein 5A (NS5A) induces the effective cellular immune response].
    Masalova OV; Lesnova EI; Grabovetskiĭ VV; Smirnova OA; Ulanova TI; Burkov AN; Ivanov AV; Zaberezhnyĭ AD; Ataullakhanov RI; Kushch AA
    Mol Biol (Mosk); 2010; 44(2):275-83. PubMed ID: 20586188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dendritic cells pulsed with hepatitis C virus NS3 protein induce immune responses and protection from infection with recombinant vaccinia virus expressing NS3.
    Yu H; Huang H; Xiang J; Babiuk LA; van Drunen Littel-van den Hurk S
    J Gen Virol; 2006 Jan; 87(Pt 1):1-10. PubMed ID: 16361412
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Monocytes transduced with lentiviral vectors expressing hepatitis C virus non-structural proteins and differentiated into dendritic cells stimulate multi-antigenic CD8(+) T cell responses.
    Jirmo AC; Koya RC; Sundarasetty BS; Pincha M; Yu GY; Lai M; Bakshi R; Schlaphoff V; Grabowski J; Behrens G; Wedemeyer H; Stripecke R
    Vaccine; 2010 Jan; 28(4):922-33. PubMed ID: 19931383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of an Outbred Rat Hepacivirus Challenge Model for Design and Evaluation of Efficacy of Different Immunization Strategies for Hepatitis C Virus.
    Atcheson E; Li W; Bliss CM; Chinnakannan S; Heim K; Sharpe H; Hutchings C; Dietrich I; Nguyen D; Kapoor A; Jarvis MA; Klenerman P; Barnes E; Simmonds P
    Hepatology; 2020 Mar; 71(3):794-807. PubMed ID: 31400152
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatitis C virus NS3/NS4A DNA vaccine induces multiepitope T cell responses in rhesus macaques mimicking human immune responses [corrected].
    Lang Kuhs KA; Ginsberg AA; Yan J; Wiseman RW; Khan AS; Sardesai NY; O'Connor DH; Weiner DB
    Mol Ther; 2012 Mar; 20(3):669-78. PubMed ID: 21952169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes.
    Brady MT; MacDonald AJ; Rowan AG; Mills KH
    Eur J Immunol; 2003 Dec; 33(12):3448-57. PubMed ID: 14635055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.